Role of α-fetoprotein in hepatocellular carcinoma: prognostication, treatment monitoring or both?

被引：12
作者：
Chan, Stephen L. [2 ]
Chan, Anthony T. C. [2 ]
Yeo, Winnie [1 ]
机构：
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China
来源：
FUTURE ONCOLOGY | 2009年 / 5卷 / 06期
关键词：
alpha-fetoprotein; hepatocellular carcinoma; monitoring treatment; prognostic factor; TRANSARTERIAL LIPIODOL CHEMOEMBOLIZATION; TRANSCATHETER ARTERIAL EMBOLIZATION; RANDOMIZED PHASE-III; MULTIVARIATE-ANALYSIS; STAGING SYSTEMS; COMBINATION CHEMOTHERAPY; RADIOFREQUENCY ABLATION; LIVER-TRANSPLANTATION; CIRRHOTIC-PATIENTS; NATURAL-HISTORY;
D O I：
10.2217/FON.09.64
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Despite recent breakthroughs in the treatment for both early and advanced hepatocellular carcinoma, the development of markers for prognostication and treatment monitoring remains to be explored. Serum alpha-fetoprotein has been frequently measured at diagnosis and serially during treatment by clinicians for decades, with an aim for prognostication of disease and monitoring of treatment response. In this review, the evidence regarding the prognostic value of serum alpha-fetoprotein and the value of serial alpha-fetoprotein In the monitoring of treatment efficacy will be discussed, with emphasis on recent data.
引用
收藏
页码：889 / 899
页数：11
相关论文
共 104 条
[1]   PRODUCTION OF EMBRYONAL ALPHA-GLOBULIN BY TRANSPLANTABLE MOUSE HEPATOMAS [J].
ABELEV, GI ;
PEROVA, SD ;
KHRAMKOVA, NI ;
POSTNIKOVA, ZA ;
IRLIN, IS .
TRANSPLANTATION, 1963, 1 (02) :174-180
[2]  
Abou-Alfa Ghassan K, 2008, Gastrointest Cancer Res, V2, P64
[3]  
BARONE RM, 1982, CANCER-AM CANCER SOC, V50, P850, DOI 10.1002/1097-0142(19820901)50:5<850::AID-CNCR2820500508>3.0.CO
[4]  
2-2
[5]   Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference [J].
Bruix, J ;
Sherman, M ;
Llovet, JM ;
Beaugrand, M ;
Lencioni, R ;
Burroughs, AK ;
Christensen, E ;
Pagliaro, L ;
Colombo, M ;
Rodés, J .
JOURNAL OF HEPATOLOGY, 2001, 35 (03) :421-430
[6]   Survival of patients with hepatocellular carcinoma in cirrhosis:: a comparison of BCLC, CLIP and GRETCH staging systems [J].
Camma, C. ;
Di Marco, V. ;
Cabibbo, G. ;
Latteri, F. ;
Sandonato, L. ;
Parisi, P. ;
Enea, M. ;
Attanasio, M. ;
Galia, M. ;
Alessi, N. ;
Licata, A. ;
Latteri, M. A. ;
Craxi, A. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (01) :62-75
[7]   A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma [J].
Chan, AO ;
Yuen, MF ;
Hui, CK ;
Tso, WK ;
Lai, CL .
CANCER, 2002, 94 (06) :1747-1752
[8]   New Utility of an Old Marker: Serial α-Fetoprotein Measurement in Predicting Radiologic Response and Survival of Patients With Hepatocellular Carcinoma Undergoing Systemic Chemotherapy [J].
Chan, Stephen L. ;
Mo, Frankie K. F. ;
Johnson, Philip J. ;
Hui, Edwin P. ;
Ma, Brigette B. Y. ;
Ho, Wing M. ;
Lam, Kwok C. ;
Chan, Anthony T. C. ;
Mok, Tony S. K. ;
Yeo, Winnie .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (03) :446-452
[9]   Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: prognostic features, treatment outcome, and survival [J].
Changchien, Chi-Sin ;
Chen, Chao-Long ;
Yen, Yi-Hao ;
Wang, Jing-Houng ;
Hu, Tsung-Hui ;
Lee, Chuan-Mo ;
Wang, Chih-Chi ;
Cheng, Yu-Fan ;
Huang, Yu-Jie ;
Lin, Chih-Yun ;
Lu, Sheng-Nan .
JOURNAL OF GASTROENTEROLOGY, 2008, 43 (02) :159-170
[10]   α-fetoprotein response predicts survival benefits of thalidomide in advanced hepatocellular carcinoma [J].
Chen, LT ;
Liu, TW ;
Chao, Y ;
Shiah, HS ;
Chang, JY ;
Juang, SH ;
Chen, SC ;
Chuang, TR ;
Chin, YH ;
Whang-Peng, J .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 (03) :217-226
12345678910